Not recruiting

Study on Fluconazole for Children and Adolescents with Fungal Infections

Verified siteRegistered drugNo placebo

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

What is this trial about?

A plain-language summary of the goals, design and what participants do

This clinical trial is focused on studying the effects of the medication fluconazole in children and adolescents aged 2 to 18 years who are dealing with invasive fungal infections. These infections are serious and can affect various parts of the body. The study aims to find the best way to dose fluconazole for young patients, whether it is given by mouth or through an intravenous infusion, which is a method of delivering medication directly into the bloodstream.

Participants in the study will receive fluconazole in different forms, including capsules, oral suspension, or as a solution for infusion. The study will observe how the body processes the medication, which is known as pharmacokinetics. This includes understanding how fluconazole is absorbed, distributed, and cleared from the body. The goal is to ensure that the medication is used effectively and safely in young patients.

The study will take place over a period of time, with participants receiving fluconazole either as a preventive measure or as a treatment for their fungal infections. The researchers will collect data to help improve the dosing guidelines for fluconazole in children and adolescents, ensuring that the medication is both effective and safe for this age group. The study will also explore factors that might affect how the medication works, such as body weight and kidney function.

The research process

The trial runs in 6 steps – from screening to follow-up. Each step says what happens and what the team monitors.

Step 1
Joining the study
Upon joining the study, you will be informed about the purpose and procedures involved. The study aims to improve the dosing regimen of fluconazole for children and adolescents aged 2-18 years with invasive fungal infections.
Step 2
Initial assessment
An initial assessment will be conducted to confirm eligibility. This includes verifying that you are between 2 and 18 years old, are being treated with fluconazole for a fungal infection, and have a central venous catheter or arterial line for blood sampling.
Step 3
Medication administration
You will receive fluconazole either orally or through an intravenous infusion. The specific form and dosage will depend on your treatment plan. Options include 50 mg capsules, 100 mg capsules, a 2 mg/ml solution for infusion, or a 10 mg/ml oral suspension.
Step 4
Ongoing monitoring
Throughout the study, regular monitoring will occur to assess how your body processes the medication. This involves blood tests to measure the concentration of fluconazole in your system.
Step 5
Data collection
Data will be collected on various factors that might influence how fluconazole works in your body, such as kidney function and body weight. This information helps in understanding the medication's effectiveness and safety.
Step 6
Completion of study
The study is expected to conclude by September 30, 2025. Upon completion, you will be informed about the findings and any implications for your treatment.

Who can join the trial?

3 criteria

The patient must be treated with fluconazole, which is a medication used to prevent or treat a serious fungal infection.
The patient must be between the ages of 2 and 18 years old on the day they first receive fluconazole.
The patient must have a central venous catheter or an arterial line, which are special tubes used to take blood samples or give medications directly into the bloodstream.

Who cannot join the trial?

6 criteria

Patients with a current or recent **fungal infection** cannot participate.
Patients who are not within the age range of **2 to 18 years** are excluded.
Patients who are not able to follow the study procedures or take the study medication as required will be excluded.
Patients who have any other medical condition that the study doctors think might make it unsafe for them to participate will not be allowed to join.
Patients who are pregnant or breastfeeding cannot take part in the study.
Patients who are participating in another clinical trial at the same time are not eligible.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

We usually reply within a few days

Verified sites

All sites with verified contact details – recruitment status may not be available; ask directly

Verified
Stichting Radboud University Medical Center
Nijmegen, The Netherlands

Trial locations

Where you can join this trial

Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.

Not recruiting

Not finding your country?

Not sure what to do next?

Joining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.

See the full process and FAQ

Investigated drugs

Fluconazole is a medication used to prevent and treat fungal infections. In this clinical trial, it is being studied to find the best way to give it to children and teenagers who have serious fungal infections. The trial is looking at how the body absorbs and processes fluconazole when it is taken by mouth or given through a vein. The goal is to find the most effective dosing plan for young patients aged 2 to 18 years, to help them fight off these infections more effectively.

Fluconazole

What is already known about the treatment

Fluconazole – Fluconazole is a medication administered either orally in pill form or intravenously through an injection, used to prevent or treat fungal infections in children and adolescents. It is well-established in medical literature as an effective antifungal agent, particularly for invasive fungal infections. The main therapeutic use of fluconazole is to combat fungal infections by inhibiting the growth of fungi. At the molecular level, it works by interfering with the cell membrane of the fungus, preventing it from producing a vital component called ergosterol, which is essential for the fungus's survival. Fluconazole is classified pharmacologically as an antifungal medication.

Investigated diseases

Fungal infection – Fungal infections are caused by fungi that invade and grow in or on the body. They can affect various parts of the body, including the skin, nails, and lungs. The progression of a fungal infection depends on the type of fungus and the area affected. Common symptoms include itching, redness, and discomfort in the affected area. In some cases, the infection can spread to other parts of the body if not managed. Fungal infections can be persistent and may require ongoing attention to prevent recurrence.